Literature DB >> 12213320

Brain-derived neurotrophic factor expression is increased in the rat amygdala, piriform cortex and hypothalamus following repeated amphetamine administration.

Gloria E Meredith1, Shannon Callen, Deborah A Scheuer.   

Abstract

The amygdala plays an important role in the regulation of motivational states, especially those associated with addiction. The amygdala also expresses high levels of brain-derived neurotrophic factor (BDNF), an activity-dependent neurotrophin that can influence the reinforcing and locomotor activating properties of psychostimulants. In the present study, we examined the effects of acute and repeated amphetamine administration on the expression and production of this factor in the forebrain of rats. Animals given a single, acute injection (5 mg/kg, i.p.) of D-amphetamine developed hyperactivity followed by stereotypical behavior but showed no change in the basal expression of BDNF mRNA or its immunocytochemical profile in any region except the piriform cortex. Repeated injections (5 days) of 5 mg/kg amphetamine were accompanied by an enhanced onset of stereotypical behavior and elevated BDNF mRNA in the basolateral amygdala, rostral piriform cortex and paraventricular nucleus of the hypothalamus. Repeated treatment also increased BDNF immunoreactivity in perikarya of these same regions. In addition, increased BDNF immunoreactivity was found in fibers of many projection targets of the basolateral amygdala--the central extended amygdala, olfactory tubercle, medial nucleus accumbens, and in small zones resembling striosomes in the dorsal medial striatum. These results suggest that the upregulation of BDNF expression and protein in the basolateral nucleus of the amygdala and its targets could be an important part of the neuroadaptive response to psychostimulants. Copyright 2002 Elsevier Science B.V.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12213320     DOI: 10.1016/s0006-8993(02)03160-8

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  50 in total

1.  (±)3,4-methylenedioxymethamphetamine ("ecstasy") treatment modulates expression of neurotrophins and their receptors in multiple regions of adult rat brain.

Authors:  Ann M Hemmerle; Jonathan W Dickerson; Nicole R Herring; Tori L Schaefer; Charles V Vorhees; Michael T Williams; Kim B Seroogy
Journal:  J Comp Neurol       Date:  2012-08-01       Impact factor: 3.215

2.  Dopamine-sensitive signaling mediators modulate psychostimulant-induced ultrasonic vocalization behavior in rats.

Authors:  Stacey N Williams; Ashiwel S Undieh
Journal:  Behav Brain Res       Date:  2015-08-11       Impact factor: 3.332

3.  Serum brain-derived neurotrophic factor levels in treatment-naïve boys with attention-deficit/hyperactivity disorder treated with methylphenidate: an 8-week, observational pretest-posttest study.

Authors:  Aynur Pekcanlar Akay; Halil Resmi; Sevay Alsen Güney; Handan Özek Erkuran; Gonca Özyurt; Enis Sargin; Ahmet Topuzoglu; Ali Evren Tufan
Journal:  Eur Child Adolesc Psychiatry       Date:  2017-07-14       Impact factor: 4.785

4.  A role for BDNF in cocaine reward and relapse.

Authors:  Geoffrey Schoenbaum; Thomas A Stalnaker; Yavin Shaham
Journal:  Nat Neurosci       Date:  2007-08       Impact factor: 24.884

5.  Synaptic Plasticity in the Bed Nucleus of the Stria Terminalis: Underlying Mechanisms and Potential Ramifications for Reinstatement of Drug- and Alcohol-Seeking Behaviors.

Authors:  Nicholas A Harris; Danny G Winder
Journal:  ACS Chem Neurosci       Date:  2018-06-13       Impact factor: 4.418

6.  Methamphetamine reversed maternal separation-induced decrease in nerve growth factor in the ventral hippocampus.

Authors:  J J Dimatelis; V A Russell; D J Stein; W M Daniels
Journal:  Metab Brain Dis       Date:  2014-01-11       Impact factor: 3.584

7.  The self-administration of rapidly delivered cocaine promotes increased motivation to take the drug: contributions of prior levels of operant responding and cocaine intake.

Authors:  Karim Bouayad-Gervais; Ellie-Anna Minogianis; Daniel Lévesque; Anne-Noël Samaha
Journal:  Psychopharmacology (Berl)       Date:  2014-04-22       Impact factor: 4.530

8.  Differential Behavioral and Biochemical Responses to Caffeine in Male and Female Rats from a Validated Model of Attention Deficit and Hyperactivity Disorder.

Authors:  Fernanda Nunes; Daniela Pochmann; Amanda Staldoni Almeida; Daniela Melo Marques; Lisiane de Oliveira Porciúncula
Journal:  Mol Neurobiol       Date:  2018-03-20       Impact factor: 5.590

9.  Restoration of amphetamine-induced locomotor sensitization in dopamine D1 receptor-deficient mice.

Authors:  Mufida B El-Ghundi; Theresa Fan; Joanna M Karasinska; John Yeung; Millee Zhou; Brian F O'Dowd; Susan R George
Journal:  Psychopharmacology (Berl)       Date:  2009-10-15       Impact factor: 4.530

Review 10.  Neuroplasticity in the mesolimbic dopamine system and cocaine addiction.

Authors:  M J Thomas; P W Kalivas; Y Shaham
Journal:  Br J Pharmacol       Date:  2008-03-17       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.